FDA moves to rehire medical device, food safety and other staffers fired days earlier
Barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected news ...
JD Supra12h
FDA Announces End to Semaglutide Shortage, Impacting Compounders and Telehealth Providers Offering Injectable GLP-1 Drugs
Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...
FDA Abruptly Halts Progress on Next Season's Flu Shots
The U.S. Centers for Disease Control says VRBPAC “makes the final decision about which vaccine viruses to include in the ...
Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
NAMI11h
NAMI Statement on FDA’s Decision to Remove Barriers to Accessing Clozapine
NAMI released the following statement from Chief Executive Officer Daniel H. Gillison, Jr., following the Food and Drug ...
Modern Healthcare13h
GLP-1 compounding pharmacies sue FDA over shortage decision
Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...
J&J Talc Settlement Blasted by Ex-FDA Head Over Asbestos Testing
A Johnson & Johnson unit working to resolve massive cancer litigation in bankruptcy court was accused by a former head of the US Food and Drug Administration of making misleading claims that the ...
Ozempic and Wegovy officially moved off FDA’s drug shortage list
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...